50,Suppl.1=20; 52,Suppl.1=21; 58,Suppl.1=23; 60,Suppl.1=24; 62,5,Suppl.1=25; 64,5,Suppl.1=26; 66,5,Suppl.1=27; 68,5,Suppl.1=28; 70,5,Suppl.1=29; 72,5,Suppl.1=30; 74,Suppl.1=31; 78,10,Suppl.1=33; 80,10,Suppl.1=34; 82,10,Suppl.1=35; 84,10,Suppl.1=36; 86,10,Suppl.1=37; 88,10,Suppl.1=38; 90,10,Suppl.1=39; 92,10,Suppl.1=40; 94,10,Suppl.1,1-2=41; 96,11,1-2=42; 98,11,1-2=43; 100,11,1-2=44; 102,11,1-2=45; 104,11,1-2=46; 106,11,1-2=47; 108,11,1-2=48; 110,11,1-2=49; 112,11=50; 114,22=51; 116,21=52; 118,21=53 von: American Society of Hematology: Annual meeting abstracts
76,Suppl.1=23 von: International Society of Haematology: Congress
Einzelne Bd. zugl. Bd. von: Conference on Folic Acid Antagonists in the Treatment of Leukemia: Proceedings of the Conference on Folic Acid Antagonists in the Treatment of Leukemia